Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 16,184Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Bausch Health, Canada Inc.

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Bausch Health, Canada Inc.

arrow
Pharmaconex
Not Confirmed

Bausch Health, Canada Inc.

Country
arrow
Pharmaconex
Not Confirmed

Halobetasol, Tazarotene

Brand Name : DUOBRII

Patent Number : 2817524

Filing Date : 2011-11-09

Strength per Unit : 0.01% w / w ; 0.045% w / w

Dosage Form : LOTION

Human Or VET : Human

Route of Administration : TOPICAL

Patent Expiration Date : 2031-11-09

Date Granted : 2019-11-05

blank

02

Bausch Health, Canada Inc.

arrow
Pharmaconex
Not Confirmed

Bausch Health, Canada Inc.

Country
arrow
Pharmaconex
Not Confirmed

Halobetasol

Brand Name : BRYHALI

Patent Number : 2417646

Filing Date : 2001-07-24

Strength per Unit : 0.01%

Dosage Form : LOTION

Human Or VET : Human

Route of Administration : TOPICAL

Patent Expiration Date : 2021-07-24

Date Granted : 2010-05-04

blank

03

Bausch Health, Canada Inc.

arrow
Pharmaconex
Not Confirmed

Bausch Health, Canada Inc.

Country
arrow
Pharmaconex
Not Confirmed

Halobetasol

Brand Name : BRYHALI

Patent Number : 2817524

Filing Date : 2011-11-09

Strength per Unit : 0.01%

Dosage Form : LOTION

Human Or VET : Human

Route of Administration : TOPICAL

Patent Expiration Date : 2031-11-09

Date Granted : 2019-11-05

blank